Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
125.16
+1.85 (1.50%)
At close: Oct 20, 2026, 4:00 PM EDT
125.54
+0.38 (0.30%)
Pre-market: Oct 21, 2026, 8:30 AM EDT

Mesa Laboratories Revenue

Mesa Laboratories had revenue of $60.14M in the quarter ending June 30, 2026, with 1.00% growth. This brings the company's total for the last twelve months to $249.73M, up 3.04% year-over-year. In the fiscal year ending March 31, 2026, Mesa Laboratories had annual revenue of $249.13M with 3.38% growth. That makes Mesa Laboratories the 15,815th largest company in the world by revenue and 2,738th in the United States.

Revenue (ttm)
$249.73M
Revenue Growth
+3.04%
P/S Ratio
2.80
Revenue / Employee
$348,291
Employees
717
Market Cap
700.38M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Sterilization and Disinfection Control 101.57M 40.8%
  • Calibration Solutions 53.55M 21.5%
  • Biopharmaceutical Development 48.63M 19.5%
  • Clinical Genomics 45.39M 18.2%

By Geography

Chart
  • United States 116.90M 46.9%
  • Other 111.79M 44.9%
  • China 20.45M 8.2%
Fiscal year ended Mar 31, 2026 See the full Mesa Laboratories breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026249.13M8.15M3.38%
Mar 31, 2025240.98M24.79M11.47%
Mar 31, 2024216.19M-2.89M-1.32%
Mar 31, 2023219.08M34.75M18.85%
Mar 31, 2022184.34M50.40M37.63%
Mar 31, 2021133.94M16.25M13.81%
Mar 31, 2020117.69M14.55M14.11%
Mar 31, 2019103.14M6.96M7.23%
Mar 31, 201896.18M2.51M2.68%
Mar 31, 201793.67M9.01M10.64%
Mar 31, 201684.66M13.33M18.69%
Mar 31, 201571.33M18.61M35.29%
Mar 31, 201452.72M6.29M13.54%
Mar 31, 201346.44M6.82M17.21%
Mar 31, 201239.62M5.39M15.74%
Mar 31, 201134.23M12.30M56.08%
Mar 31, 201021.93M393.00K1.82%
Mar 31, 200921.54M1.98M10.11%
Mar 31, 200819.56M2.32M13.43%
Mar 31, 200717.24M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.